Skip to content
Open access

An atfs-1 loss-of-function screen identifies novel regulators of α-synuclein toxicity in C. elegans dopaminergic neurons

Aug 2026 · bioRxiv · 0 citations · 1 references
Medicine Biology

TL;DR

Results provide evidence that jmjd-1.2 and jmjd-3.1 naturally confer protection from α-syn-induced neurotoxicity, and are used to examine the association of these gene products in DA neurodegeneration.

Abstract

Overexpression of α-synuclein (α-syn), an inherently disordered protein, triggers chronic activation of the mitochondrial unfolded protein response (UPRmt) pathway in Caenorhabditis elegans with enhanced dopaminergic (DAergic) neurodegeneration. Introduction of a loss-of-function(lf) mutation in atfs-1, the main transcriptional regulator of the UPRmt, into α-syn nematodes results in significant neuroprotection from α-syn-induced DA neuron loss. Using this sensitized neuroprotective background, we performed a F3 forward genetic screen in C. elegans atfs-1(lf) mutants to identify molecular components associated with the modulation of neurodegeneration in α-syn-expressing DA neurons. Homozygous mutant animals were examined for enhanced neurodegeneration; multiple independent alleles were uncovered. Among these, we identified new nonsense alleles encoding the histone lysine demethylases (H3K27me3), jmjd-1.2 (orthologous to human KDM7A, PHF2, and PHF8) and jmjd-3.1 (homologous to yeast CYC8). Another line carried a nonsense allele of twk-14. This gene encodes a conserved protein termed KCNK12 in mammals that facilitates passive background K+ leak currents to set and stabilize resting membrane potential. To further examine the association of these gene products in DA neurodegeneration, we used neuron-specific RNA interference, mutants, or both. DA neurodegeneration was observed in the α-syn + atfs-1(lf) background when jmjd-1.2, jmjd-3.1, or twk-14 were individually depleted. These results provide evidence that jmjd-1.2 and jmjd-3.1, which encode previously characterized H3K27me3 demethylases, and the uncharacterized twk-14 gene product, orthologous to human KCNK12, naturally confer protection from α-syn-induced neurotoxicity.

Read PDF

Similar papers

Open access Sep 2026

Cellular prion protein levels modulate nigrostriatal vulnerability to α-synuclein oligomers in Parkinson’s disease

PrPC expression levels are identified as an important modulator of nigrostriatal vulnerability and neuroinflammatory phenotype in response to αSynO, supporting the hypothesis that PrPC contributes to αSynO-mediated pathogenic mechanisms.

Flavio de Souza Júnyor, F. Leser, Sarah de Souza Albuquerque et al. · 0 citations
#gene editing Open access Aug 2026

Nigral DJ-1 gene knockout in tree shrews can induce phosphorylated α-synuclein aggregation and all key phenotypes of Parkinson’s disease

In vivo evidence is provided supporting a model in which DJ-1 deficiency can promote key PD-like phenotypes in tree shrews, potentially involving PSer129αSyn accumulation, nigral dopaminergic neuron loss, and motor dysfunction.

Hao Li, Leyi Mei, Jing-Mei Cha et al. · 0 citations
Open access May 2024

Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson’s disease

Neuronal α-synucleinopathies, including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), lack disease-modifying therapies. We developed a Drosophila model for identifying novel glial-based therapeutic targets for α-synucleinopathies. In this model, human α-synuclein is expressed in neurons and individual g...

MJ Sodders, J. Ávila-Pacheco, EC Okorie et al. · 1 citation
Open access Aug 2026

α-Synuclein impairs mitochondrial function and alters cryptochrome regulation in the substantia nigra

Data provide evidence of a specific window of time during which sustained α-synuclein burden results in direct α-synuclein-mitochondria interactions and nigral mitochondrial damage and a specific remodeling of molecular clock components occurs, providing a potential new mechanism contributing to metabolic and mitochond...

S. O’Sullivan, Adrian Kacperczyk-Perdyan, A. Ulusoy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.